SUD I - Opioid-Related Disorders Cheat Sheet: by Via
SUD I - Opioid-Related Disorders Cheat Sheet: by Via
SUD I - Opioid-Related Disorders Cheat Sheet: by Via
Prescribing Restrictions: Opioid Occurs when the body adjusts its normal functioning
Schedule III Depen around regular opioid use (unpleasant physical symptoms
DATA waiver dence occurs when med is stopped)
Initial no. of pts is 30 Opioid Occurs when attempts to cut down use are unsuccessful
May apply 1 year to increase no. of patients to 100, then 275 Addict‐ or when results insocial problems and a failure to fulfill
DEA number will begin with X ion obligations; often comes after person has developed
opioid tolerance and dependence
Signs and Sx of opioid WITHDRAWAL
WITHDRAWAL TIMELINE
Onset of withdrawal will depend upon the half-life of the opioid used
(normally within 36 to 72 hours)
Completed within 7 days for short acting opioids (heroin) and 14
days for long-acting opioids (buprenorphine, methadone)
Cravings or a strong desire to use Monitoring Tolerability, respiratory depression, HR/BP, EKG,
electrolytes, UDS, urine methadone, PMP
Recurrent use resulting in a failure to fulfill major obligations
Clinical prolonged or delayed withdrawal due to long half-life;
Continued use despite having persistent social or interpersonal
Pearls overdose risk is highest during initial 2 weeks of
problems caused by the substance
treatment
Important social, occupational, or recreational activities are given up
Prescribing restrictions:
or reduced
- schedule II; restricted to certified opioid treatment program (OTP)
Recurrent use in situations that are physically hazardous
- it is not appropriate to dispense methadone from a community
Recurrent use despite knowledge of having a persistent or recurrent pharmacy for the purposes of opioid detox, withdrawal, or mainte‐
physical or psychological problem due to use nance
Tolerance - pts must be currently addicted and have opioid use disorder ≥ 1
Withdrawal year
- exceptions: pregnancy, recently released from correction, and
FIRST - LINE TREATMENT previous treatment in OTP
Narcan Formulations
Naloxone IM/IV/SQ
Naloxone Intranasal
Evzio IM auto-injector
Narcan Intranasal